COPENHAGEN — Novo Nordisk has obtained approval for the pill form of its popular Wegovy anti-obesity drug in the European Union, the bloc's medicin...

A new and higher dose of obesity drug Wegovy has joined Novo Nordisk’s semaglutide portfolio, giving patients and doctors more options for treatment.

Die EU-Arzneimittelbehörde macht den Weg frei für die europaweit erste Abnehmpille. Hersteller Novo Nordisk sichert sich damit einen entscheidenden Vorsprung vor der US-Konkurrenz.

COPENHAGEN — Novo Nordisk has obtained approval for the pill form of its popular Wegovy anti-obesity drug in the European Union, the bloc's medicin...